Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol for Subclinical Anthracycline-Related Cardiac Dysfunction
NCT03542058Phase 3Unknown
- Sponsor
- Makerere University
- Start
- Jun 2018
- Primary completion
- Jun 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of carvedilol in anthracycline-induced cardiotoxicity, sponsored by Makerere University. Status: unknown.
02
Drugs
carvedilol
03
Conditions
anthracycline-induced cardiotoxicity
Beyond the preview
Go deeper on NCT03542058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03542058.